HLA typing and epitope mapping guide to HIV vaccine design
Ended Definitive Contract Awarded Last action
- Contract number
- 00266200105D266015442
- Awardee
-
The General Hospital Corporation UEI FLJ7DQKLL226
- Awarding agency
-
NIAID DEA OA Acquisitions
National Institutes of Health, Department of Health and Human Services
- Obligated
- $10,491,241
Award facts
- Contract value 31% obligated
-
- $32,084,163.00 Current, with exercised options
- $33,826,992.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- Not on record
- PSC
- C118 Research And Development Facilities
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers
- Pricing
- Cost No Fee
- Place of performance
- Boston, MA 02114, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$1,055 | |
| Other Administrative Action | -$1,055 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $992,829 | |
| Funding Only Action | $434,663 | |
| Funding Only Action | $2,347,788 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $250,000 | |
| Supplemental Agreement for work within scope | $1,786,071 | |
| Supplemental Agreement for work within scope | $500,000 | |
| Supplemental Agreement for work within scope | $1,744,000 | |
| Original award | $2,438,000 |
Show all 14
About this award
This is a definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), for $33,826,992.00. The contract is for HIV vaccine design research, including human leukocyte antigen (HLA) typing and epitope mapping. The contract has no set-aside designation.
MGH is a non-profit, 999-bed teaching hospital affiliated with Harvard Medical School that conducts extensive biomedical research, including clinical trials, laboratory studies, and medical countermeasure development across a range of disease areas. MGH has secured significant grant funding from the National Institutes of Health (NIH) for cutting-edge research projects, and frequently partners with academic institutions through sub-awards. Additionally, MGH holds an indefinite delivery contract with the Department of Veterans Affairs to provide research and development services supporting the BrainGate ALS Hand Studies program.
Quick answers
Who was awarded contract 00266200105D266015442?
00266200105D266015442 was awarded to The General Hospital Corporation by NIAID DEA OA Acquisitions (National Institutes of Health) on May 15, 2001.
How much is contract 00266200105D266015442 worth?
The government has obligated $10,491,241 on 00266200105D266015442. Its current value, with exercised options, is $32,084,163. Its potential value, with all options, is $33,826,992.
Was contract 00266200105D266015442 competed?
The extent of competition for 00266200105D266015442 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award